Literatur
-
1
Bausch D G, Feldmann H, Geisbert T W. et al .
Outbreaks of filovirus hemorrhagic fever: time to refocus on the patient.
J Inf Dis.
2007;
196 (Suppl 2)
S136-S141
-
2
Borio L, Inglesby T, Peters C J. et al .
Hemorrhagic fever viruses as biological weapons: medical and public health management.
JAMA.
2002;
287
2391-2405
-
3 Bundesamt für Bevölkerungsschutz und Katastrophenhilfe .Biologische Gefahrenlagen, Band II, 1. Aufl. Bonn; 2007
-
4
Burchard G D.
Fieber nach Tropenaufenthalt.
Internist (Berl).
1999;
40
1143-1149
-
5
Carneiro S C, Cestari T, Allen S H. et al .
Viral exanthems in the tropics.
Clin Dermatol.
2007;
25
212-220
-
6
Delgado S, Erickson B R, Agudo R. et al .
Chapare virus, a newly discovered arenavirus isolated from a fatal hemorrhagic fever case in Bolivia.
PLoS Pathog.
2008;
4
e1000047
-
7
Fock R. et al .
Schutz vor lebensbedrohenden importierten Infektionskrankheiten.
Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz.
2000;
43
891-899
-
8
Fock R. et al .
Management und Kontrolle lebensbedrohender hochkontagiöser Infektionskrankheiten.
Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz.
1999;
42
389-401
-
9
Fock R. et al .
Erste medizinische und antiepidemische Maßnahmen bei Verdacht auf VHF.
Med Welt.
2001;
52
126-132
-
10
Haas W H, Breuer T, Pfaff G. et al .
Imported Lassa fever in Germany: surveillance and management of contact persons.
Clin Infect Dis.
2003;
36
1254-1258
-
11
Inglesby T V. et al .
Plague as a biological weapon. Medical and public health management.
JAMA.
2000;
283
2281-2290
-
12
Isaäcson M.
Viral hemorrhagic fever hazards for travelers in Africa.
CID.
2001;
33
1707-1712
-
13
Macher A M, Wolfe M S.
Historical Lassa fever reports and 30-year clinical update.
Emerg Inf Dis.
2006;
5
835-837
-
14
Pigott D C.
Hemorrhagic fever viruses.
Crit Care Med.
2005;
21
765-783
-
15
Reynolds M G, Davidson W B, Curns A T. et al .
Spectrum of infection and risk factors for human monkeypox, United States, 2003.
Emerg Infect Dis.
2007;
13
1332-1339
-
16
Richmond J K, Baglole J.
Lassa fever: epidemiology, clinical features, and social consequences.
BMJ.
2003;
327
1271-1275
-
17
Stich A.
Hochkontagiöse Erkrankungen in Deutschland.
Flug-, Tropen- und Reisemedizin.
2008;
15
31-34
-
18
Vorou R, Pierroutsakos I N, Maltezou H C.
Crimean-Congo hemorrhagic fever.
Curr Opin Infect Dis.
2007;
20
495-500
-
19
Weber D J. et al .
Risks and prevention of nosocomial transmission of rare zoonotic diseases.
Clin Infect Dis.
2001;
32
446-456
-
20
Wirtz A, Niedrig M, Fock R.
Management of patients in Germany with suspected viral haemorrhagic fever and other potentially lethal contagious infections.
Euro Surveill.
2002;
7
36-42
-
21
Woodrow C J, Eziefula A C, Agranoff D. et al .
Early risk assessment for viral hemorrhagic fever: experience at the Hospital for Tropical Diseases, London, UK.
J Inf.
2007;
54
6-11
-
22
Bannister B, Puro V, Fusco F M, Heptonstall J, Ippolito G, Working Group E UNID.
Framework for the design and operation of high-level isolation units: consensus of the European Network of Infectious Diseases.
Lancet Infect Dis.
2009;
9
45-56
Internet
Prof. Dr. Gerd Burchard
Sektion Tropenmedizin, Bernhard-Nocht-Klinik für Tropenkrankheiten
Universitätsklinik Hamburg-Eppendorf
1. Medizinische Klinik
Bernhard-Nocht-Str. 74
20359 Hamburg
Telefon: 040 42818391
Fax: 040 42818394
eMail: gerd.burchard@bni-hamburg.de